QNCX

Quince Therapeutics Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Quince Therapeutics Inc is focused on the development of innovative therapies for the treatment of serious neurological diseases.

$ 1.34
5.51 %

Quince Therapeutics Inc

$ 1.34
5.51 %
QNCX

Quince Therapeutics Inc is focused on the development of innovative therapies for the treatment of serious neurological diseases.

Price history of Quince Therapeutics Inc
Price history of Quince Therapeutics Inc

Performance & Momentum

6 Months 92.64 %
1 Year 87.24 %
3 Years 91.35 %
5 Years 99.65 %

Strategic Analysis

Quince Therapeutics Inc • 2026

Quince Therapeutics Inc is a small U.S. biopharmaceutical company focused on developing treatments for severe neurological diseases, an area where value depends mainly on clinical and regulatory success. Its positioning is therefore based on a highly targeted specialization strategy, with significant upside potential if medical validation is achieved, but still limited commercial visibility.

Strengths
  • Focus on severe and underserved medical needs, which can create substantial clinical value if the programs succeed
  • Exposure to the innovative therapies segment, where a clinical breakthrough can quickly re-rate the stock
  • Niche profile that may attract investors specialized in biotech names with high innovation leverage
Weaknesses
  • High dependence on clinical trial outcomes and regulatory decisions, with significant binary risk
  • Extremely poor stock market history, reflecting severely weakened market confidence and likely or feared heavy capital dilution
  • Limited short-term operational visibility in a biotech universe where the absence of favorable news can quickly weigh on valuation
Momentum

Momentum is very weak and the underlying trend remains clearly bearish, indicating a market that is still cautious, if not skeptical, about the stock. In the absence of recent news capable of reviving the investment thesis, the share retains a highly speculative profile, with rebound potential only if a credible clinical or regulatory catalyst emerges.

Similar stocks to Quince Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone